升主动脉瘤中动脉粥样硬化、炎症与退行性变的复杂交互
本研究对255例升主动脉瘤手术标本行组织病理学检查,采用欧洲心血管病理学会和心血管病理学会更新的分类。结果显示退行性变占67.5%,动脉粥样硬化占18.8%,主动脉炎占13.7%。动脉粥样硬化和炎症显著参与慢性胸主动脉疾病的发展。
要点
- 升主动脉瘤组织病理以退行性变为主,但动脉粥样硬化和主动脉炎占比可观。
- 退行性变患者更常合并二叶式主动脉瓣。
- 动脉粥样硬化及主动脉炎患者更常合并腹主动脉瘤。
核心结论
- 退行性组织病理是升主动脉瘤最常见的基础,但动脉粥样硬化和炎症显著参与慢性胸主动脉疾病的发展。
研究设计与样本
- 纳入255例因升主动脉瘤行手术的患者,对其升主动脉手术标本进行组织病理学检查,并应用欧洲心血管病理学会和心血管病理学会更新的非炎症性退行性和炎症性主动脉疾病分类。
主要发现
- 升主动脉瘤的组织病理学基础主要为退行性变(67.5%),但动脉粥样硬化病变(18.8%)和主动脉炎(13.7%)的患病率也值得注意。
- 退行性变患者更常合并二叶式主动脉瓣(37.2%;P = .002)。
- 动脉粥样硬化组患者年龄更大(中位年龄69岁;P < .001),更多有高血压史(87.5%;P = .059)、高胆固醇血症(75%;P = .019)、糖尿病(16.6%;P = .054)、当前吸烟(22.9%;P = .066)和冠心病史(18.7%;P = .063)。
- 主动脉炎患者年龄最大(中位年龄75岁,P < .001),多为女性(68.6%;P < .001),升主动脉直径更大(中位56 mm;P < .001)。
- 动脉粥样硬化和主动脉炎患者合并腹主动脉瘤的发生率更高(分别为20.8%和22.8%;P < .001)。
临床怎么用
- 在升主动脉瘤患者中,应关注动脉粥样硬化和炎症的共存,尤其对高龄、女性、合并腹主动脉瘤或心血管危险因素者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the histopathological findings of a large series of ascending thoracic aortic aneurysm (TAA) surgical specimens applying the updated classification on noninflammatory degenerative and inflammatory aortic diseases proposed by the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology clinicopathological correlations. METHODS: A total of 255 patients surgically treated for ascending TAA were enrolled. Surgical ascending aorta specimens were examined. RESULTS: The histopathological substrate of ascending TAAs was mainly degenerative (67.5%), but with a remarkable prevalence of atherosclerotic lesions (18.8%) and aortitis (13.7%). Degenerative patients more frequently had bicuspid aortic valve (37.2%; P = .002). Patients in the atherosclerotic group were older (median age, 69 years; P < .001), more often with a history of hypertension (87.5%; P = .059), hypercholesterolemia (75%; P = .019), diabetes (16.6%; P = .054), current smoking (22.9%; P = .066), and a history of coronary artery disease (18.7%; P = .063). Patients with aortitis represented the older group (median age, 75 years, P < .001), were mostly females (68.6%; P < .001), and had a larger ascending aorta diameter (median, 56 mm; P < .001). Both patients with atherosclerosis and aortitis presented a higher incidence of concomitant abdominal aortic aneurysm (20.8% and 22.8%, respectively; P < .001). CONCLUSIONS: Although degenerative histopathology is the most frequent substrate in ascending TAA, atherosclerosis and inflammation significantly contribute to the development of chronic aortic thoracic disease.
引用
- Leone O, Corsini A, Pacini D, et al. The complex interplay among atherosclerosis, inflammation, and degeneration in ascending thoracic aortic aneurysms. J Thorac Cardiovasc Surg. 2019. PMID: 31706551. doi:10.1016/j.jtcvs.2019.08.108
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。